▶︎
AUA Newsworthy Webinar: Update on PSMA PET/CT in Prostate Cancer & the Unmet Need for Imaging of RCC
▶︎
Global Perspectives: Pediatric Urology Across Borders
▶︎
ADT for Prostate Cancer: Agonists vs Antagonists
▶︎
Quality Improvement Project Guide: Planning a QI Intervention (2 of 4)
▶︎
Training Transformed: University of California San Francisco
▶︎
Reframing Menopause Care: Vaginal Estrogen, GSM, & Breaking the Fear Barrier
▶︎
AUA2026 Ramon Guiteras Lecture Spotlight: Overdiagnosis, Screening & the Cost of Finding Too Much
▶︎
Breaking Research from The Atlas Study Group - NMIBC News
▶︎
Apalutamide vs Enzalutamide: Insights on Real-World Survival Benefits and Clinical Implications
▶︎
Determining the Benefit of Therapy for Biochemically Recurrent Prostate Cancer with Dr. Einstein
▶︎
Your Kidneys are Begging You to Eat These 5 FRUITS (Lower Creatinine Naturally After 60)
▶︎
Global Perspectives: Lessons in Innovation, Resourcefulness, & Collaboration from Brazil
▶︎
The Power Of Exercise For Prostate Cancer | Robert Newton, PHD & Q+A with Mark Moyad, MD #PCRI
▶︎
ArteraAI: The Biomarker Test Redefining #ProstateCancer Hormone Therapy | #MarkScholzMD #AlexScholz
▶︎
Exploring Mentorship in Urology: Insights from the FUTURE Program at AUA2026
▶︎
Intermediate risk prostate cancer
▶︎
More on Localized Prostate Cancer
▶︎
What is the ideal duration of hormone therapy for the treatment of prostate cancer?
▶︎
Active Surveillance: Intermediate Disease and High-Volume Grade Group 1 Prostate Cancer
▶︎